Geron (GERN) Change in Acquisitions & Divestments (2010 - 2026)
Geron's (GERN) quarterly Change in Acquisitions & Divestments came in at $86.6 million in Q1 2026, down 12.39% year-on-year from $98.9 million in Q1 2025, and down 30.89% quarter-over-quarter from $125.4 million in Q4 2025.
Geron (GERN) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Geron has disclosed Change in Acquisitions & Divestments across 17 years of filings, most recently posting $86.6 million for Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $86.6 million, down 12.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $399.5 million (up 7.95% YoY), and the FY2025 annual result was $411.7 million, up 10.79% from the prior year.
- Change in Acquisitions & Divestments came in at $86.6 million for Q1 2026 at Geron, down from $125.4 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $179.8 million in Q4 2022 to a low of $41.8 million in Q2 2022.
- The 5-year median for Change in Acquisitions & Divestments is $86.6 million (2026), against an average of $87.4 million.
- Across the five-year window, Change in Acquisitions & Divestments soared 159.0% in 2022 and tumbled 64.68% in 2023, its largest moves.
- Geron's Change in Acquisitions & Divestments stood at $179.8 million in 2022, then sank by 64.68% to $63.5 million in 2023, then climbed by 27.78% to $81.1 million in 2024, then surged by 54.51% to $125.4 million in 2025, then plunged by 30.89% to $86.6 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $86.6 million (Q1 2026), $125.4 million (Q4 2025), and $90.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.63 Mn |
| Mar 31, 2026 | 86.63 Mn |
| Dec 31, 2025 | 125.36 Mn |
| Dec 31, 2025 | 125.36 Mn |
| Sep 30, 2025 | 90.29 Mn |
| Sep 30, 2025 | 90.29 Mn |
| Jun 30, 2025 | 97.18 Mn |
| Jun 30, 2025 | 97.18 Mn |
| Mar 31, 2025 | 98.88 Mn |
| Mar 31, 2025 | 98.88 Mn |
| Dec 31, 2024 | 81.14 Mn |
| Dec 31, 2024 | 81.14 Mn |
| Sep 30, 2024 | 65.25 Mn |
| Sep 30, 2024 | 65.25 Mn |
| Jun 30, 2024 | 124.78 Mn |
| Jun 30, 2024 | 124.78 Mn |
| Mar 31, 2024 | 100.44 Mn |
| Mar 31, 2024 | 100.44 Mn |
| Dec 31, 2023 | 63.50 Mn |
| Dec 31, 2023 | 63.50 Mn |